通过基于金属有机框架的纳米酶优化癌症治疗
Qinxin Zhang1, Sai Chen2, Hongwei Zhang3
1Hebei Key Laboratory of Medical-Industrial Integration Precision Medicine, School of Clinical Medicine, North China University of Science and Technology, Tangshan 063000, China; Key Laboratory of Carbon Materials of Zhejiang Province, Wenzhou University, Wenzhou 325035, China.
International journal of biological macromolecules
|February 24, 2025
概括
基于金属有机框架 (MOF) 的纳米酶为克服常规癌症治疗的局限性提供了一个有希望的策略. 这些先进的纳米材料通过各种催化活动和治疗方法来提高治疗效率.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症是一个重大的全球健康挑战,常规治疗常常受到药物耐药性和不良影响的限制.
- 纳米酶,具有类似酶的催化性能的纳米材料,由于其效率和生物相容性,具有癌症治疗的潜力.
- 金属有机框架 (MOFs) 提供可调节的结构,非常适合设计先进的纳米酶.
研究的目的:
- 审查基于MOF的纳米酶的最新进展,以优化癌症治疗.
- 根据它们的酶模仿活动和催化机制来分类基于MOF的纳米酶.
- 在各种癌症治疗模式中突出利用基于MOF的纳米酶的治疗策略.
主要方法:
- 基于酶仿真 (过氧化酶,氧化酶,催化酶,超氧化物转化酶) 的MOF纳米酶的分类及其机制的讨论.
- 探索新兴的单原子纳米酶.
- 分析治疗策略,包括饥饿疗法,氧气供应,催化疗法和谷氨耗尽.
主要成果:
- 基于MOF的纳米酶表现出可调节的特性,用于增强催化活性和治疗应用.
- 这些纳米酶可以被设计为特定的酶模拟功能,并集成到各种癌症治疗模式中.
- 策略利用MOF特性来改善向,减少毒性,并提高化疗,放射治疗,光动力学和声动力学疗法的结果.
结论:
- 基于MOF的纳米酶代表了下一代癌症治疗的多功能平台.
- 它们的可调性性质和催化效率提供了改善的治疗结果,降低了全身毒性.
- 进一步开发具有很大的潜力,可以推进个性化和有效的癌症治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:46Electron Transport Chain: Complex I and II
10.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.2K